Palo Alto Investors LP Closed Holding Positions

Palo Alto Investors LP

  • $727 Million
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
KLDO
Kaleido Biosciences, Inc.

Healthcare
Q2 2022 Filed on Aug 15, 2022
309,692
$0.05 - $1.7 $15.5K - $526K
RIGL
Rigel Pharmaceuticals Inc

Healthcare
Q2 2022 Filed on Aug 15, 2022
652,395
$0.67 - $3.19 $437K - $2.08M
Zogenix Inc
Q1 2022 Filed on May 16, 2022
183,800
N/A
AZN
Astrazeneca PLC

Healthcare
Q1 2022 Filed on May 16, 2022
29,260
$55.72 - $67.12 $1.63M - $1.96M
IDRA
Idera Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
77,044
$0.53 - $1.03 $40.8K - $79.4K
PBYI
Puma Biotechnology, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
1,392,997
$2.85 - $6.58 $3.97M - $9.17M
Minerva Neurosciences Inc
Q4 2021 Filed on Feb 14, 2022
36,319
N/A
Dicerna Pharmaceuticals Inc
Q4 2021 Filed on Feb 14, 2022
855,713
N/A
VIRX
Viracta Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
33,212
$3.37 - $7.91 $112K - $263K
ATNX
Athenex, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
318,200
$1.36 - $2.94 $433K - $936K
SYRS
Syros Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
80,600
$3.26 - $4.66 $263K - $376K
Alexion Pharmaceuticals Inc
Q3 2021 Filed on Nov 15, 2021
94,850
N/A
APRE
Aprea Therapeutics, Inc.

Healthcare
Q1 2021 Filed on May 17, 2021
128,770
$4.73 - $8.15 $609K - $1.05M
Sunesis Pharmaceuticals Inc
Q1 2021 Filed on May 17, 2021
116,246
N/A
Marinus Pharmaceuticals Inc
Q1 2021 Filed on May 17, 2021
31,330
N/A
EOLS
Evolus, Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
265,700
$2.92 - $4.84 $776K - $1.29M
Immunomedics Inc
Q4 2020 Filed on Feb 16, 2021
4,852,383
N/A
Amag Pharmaceuticals Inc
Q4 2020 Filed on Feb 16, 2021
3,003,875
N/A
TCDA
Tricida, Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
170,800
$4.37 - $9.46 $746K - $1.62M
Retrophin Inc
Q4 2020 Filed on Feb 16, 2021
157,900
N/A
Momenta Pharmaceuticals Inc
Q3 2020 Filed on Nov 16, 2020
1,479,524
N/A
ITCI
Intra Cellular Therapies, Inc.

Healthcare
Q3 2020 Filed on Nov 16, 2020
37,400
$17.61 - $31.86 $659K - $1.19M
Wright Medical Group Nv
Q2 2020 Filed on Aug 14, 2020
242,940
N/A
Alimera Sciences Inc
Q2 2020 Filed on Aug 14, 2020
200,919
N/A
Melinta Therapeutics Inc
Q1 2020 Filed on May 15, 2020
10,137
N/A
Sophiris Bio Inc
Q1 2020 Filed on May 15, 2020
247,000
N/A
GILD
Gilead Sciences, Inc.

Healthcare
Q1 2020 Filed on May 15, 2020
39,300
$62.63 - $80.22 $2.46M - $3.15M
Alder Biopharmaceuticals Inc
Q4 2019 Filed on Feb 14, 2020
1,861,630
N/A
Celgene Corp
Q4 2019 Filed on Feb 14, 2020
21,883
N/A
EXAS
Exact Sciences Corp

Healthcare
Q3 2019 Filed on Nov 14, 2019
314,889
$90.37 - $122.49 $28.5M - $38.6M
Histogenics Corp
Q3 2019 Filed on Nov 14, 2019
302,922
N/A
Melinta Therapeutics Inc
Q1 2019 Filed on May 15, 2019
50,689
N/A
Shire PLC
Q1 2019 Filed on May 15, 2019
47,938
N/A
TRVN
Trevena Inc

Healthcare
Q4 2018 Filed on Feb 14, 2019
341,300
$0.39 - $3.47 $133K - $1.18M
Idera Pharmaceuticals Inc
Q3 2018 Filed on Nov 14, 2018
616,355
N/A
Bioverativ Inc
Q1 2018 Filed on May 15, 2018
264,400
N/A
Cempra Inc
Q4 2017 Filed on Feb 14, 2018
340,320
N/A
ACRX
Acelrx Pharmaceuticals Inc

Healthcare
Q4 2017 Filed on Feb 14, 2018
1,032,715
$1.75 - $5.5 $1.81M - $5.68M
Alcobra LTD
Q4 2017 Filed on Feb 14, 2018
272,788
N/A
Soleno Therapeutics Inc
Q4 2017 Filed on Feb 14, 2018
84,748
N/A
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email